ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
17.04159
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,470.55
-0.02%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Caribou Biosciences Inc (CRBU)

  7. Caribou Biosciences Inc (CRBU) Noticias

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CRBU
FechaHoraFuenteTítuloSímboloCompañía
30/05/202415:01GlobeNewswire Inc.Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
07/05/202415:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
07/05/202415:05GlobeNewswire Inc.Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
01/05/202415:05GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
24/04/202409:00GlobeNewswire Inc.Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
15/04/202408:00GlobeNewswire Inc.Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)NASDAQ:CRBUCaribou Biosciences Inc
04/04/202415:00GlobeNewswire Inc.Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in LupusNASDAQ:CRBUCaribou Biosciences Inc
11/03/202416:08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRBUCaribou Biosciences Inc
11/03/202415:25Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRBUCaribou Biosciences Inc
11/03/202415:05GlobeNewswire Inc.Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
05/03/202415:30GlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
22/02/202416:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
10/01/202415:18Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
09/01/202415:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
08/01/202415:18Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBUCaribou Biosciences Inc
07/01/202410:00GlobeNewswire Inc.Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024NASDAQ:CRBUCaribou Biosciences Inc
13/12/202305:30IH Market NewsCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend For Twelfth Year, and Latest UpdatesNASDAQ:CRBUCaribou Biosciences Inc
12/12/202317:26Dow Jones NewsCaribou Biosciences Shares Rise 4.1% as FDA Approves Lymphoma TrialNASDAQ:CRBUCaribou Biosciences Inc
12/12/202315:02GlobeNewswire Inc.Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024NASDAQ:CRBUCaribou Biosciences Inc
17/11/202315:06Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
07/11/202315:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBUCaribou Biosciences Inc
07/11/202315:00GlobeNewswire Inc.Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
06/11/202307:00GlobeNewswire Inc.Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory BoardNASDAQ:CRBUCaribou Biosciences Inc
18/10/202307:00GlobeNewswire Inc.Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaNASDAQ:CRBUCaribou Biosciences Inc
27/09/202307:00GlobeNewswire Inc.Caribou Biosciences Appoints Reigin Zawadzki as Chief People OfficerNASDAQ:CRBUCaribou Biosciences Inc
08/08/202315:00GlobeNewswire Inc.Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
14/07/202316:31Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRBUCaribou Biosciences Inc
14/07/202315:22Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
14/07/202306:51IH Market NewsFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase, UPS, Theseus Pharmaceuticals, and moreNASDAQ:CRBUCaribou Biosciences Inc
13/07/202322:15GlobeNewswire Inc.Caribou Biosciences Announces Pricing of Upsized $125 Million Public OfferingNASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU

Su Consulta Reciente

BIT
S29350
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados